Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 13/20 | 0.61 |
| ▸ | RAB9A | P51151 | 13/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 10/20 | 0.61 |
| ▸ | MAPT | P10636 | 8/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.61 |
| ▸ | MEN1 | O00255 | 6/20 | 0.61 |
| ▸ | CASP3 | P42574 | 1/20 | 0.61 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.61 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.61 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.56 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 5/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 5/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3112891 | 0.83 | NPC1 (0.78) | IDO1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL30073965 | 0.83 | NPC1 (0.78) | IDO1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL29909885 | 0.79 | IDO1 (0.66) | IDO1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL11592408 | 0.79 | IDO1 (0.66) | IDO1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL2353642 | 0.79 | IDO1 (0.66) | IDO1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL758888 | 0.79 | IDO1 (0.66) | IDO1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL1132595 | 0.79 | IDO1 (1.00) | IDO1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL17833027 | 0.79 | IDO1 (0.66) | IDO1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL11592410 | 0.79 | IDO1 (0.66) | IDO1NPC1RAB9ASMN1; SMN2MAPT | |
| Hydrochloric Acid SCHEMBL3130678 | 0.78 | IDO1 (0.63) | IDO1NPC1RAB9ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101139338-B | Preparation of 2,2'-disulfo-dibenzopyrene by oxygen process based on 2-mercaptan benzothiazole ammonia salt | QINGDAO TECHNOLOGY UNIVERSITY | 2013-10-23 | — | — | CN | claimed |
| CN-101139338-A | Preparation of 2,2-disulfo-dibenzopyrene by oxygen process based on 2-mercaptan benzothiazole ammonia salt | QINGDAO TECHNOLOGY UNIVERSITY (CN) | 2008-03-12 | — | — | CN | claimed |
| CN-118251316-A | Pneumatic tire | 株式会社普利司通 | 2024-06-25 | — | — | CN | disclosed |
| EP-3312160-B1 | HEPATITIS B ANTIVIRAL AGENTS | NOVIRA THERAPEUTICS INC (US) | 2020-03-18 | — | — | EP | disclosed |
| US-9981929-B2 | Method for prevention of premature polymerization | NITTO BELGIUM NV (BE) | 2018-05-29 | — | — | US | disclosed |
| EP-3312160-A1 | HEPATITIS B ANTIVIRAL AGENTS | Novira Therapeutics Inc. (US) | 2018-04-25 | — | — | EP | disclosed |
| US-20170369458-A1 | METHOD FOR PREVENTION OF PREMATURE POLYMERIZATION | NITTO EUROPE N.V. (BE) | 2017-12-28 | — | — | US | disclosed |
| US-9796693-B2 | Method for prevention of premature polymerization | NITTO EUROPE N.V. (BE) | 2017-10-24 | — | — | US | disclosed |
| US-20160280673-A1 | METHOD FOR PREVENTION OF PREMATURE POLYMERIZATION | NITTO EUROPE N.V. (BE) | 2016-09-29 | — | — | US | disclosed |
| EP-3072879-A1 | METHOD FOR PREVENTION OF PREMATURE POLYMERIZATION | NITTO EUROPE N.V (BE) | 2016-09-28 | — | — | EP | disclosed |
| US-5032588-A | Non-steroidal antiinflammatory | ABBOTT LABORATORIES (US) | 1991-07-16 | — | — | US | disclosed |
| WO-1991008744-A1 | THIAZOLE LIPOXYGENASE-INHIBITING COMPOUNDS DERIVED FROM NON-STEROIDAL ANTIINFLAMMATORY CARBOXYLIC ACIDS | ABBOTT LABORATORIES (US) | 1991-06-27 | — | — | WO | disclosed |
| US-4271308-A | FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1981-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160280673-A1 | METHOD FOR PREVENTION OF PREMATURE POLYMERIZATION | PGF, TTPA, MLN | IDO1 4105/4885NPC1 322/4885RAB9A 4435/4885 |
| US-20170369458-A1 | METHOD FOR PREVENTION OF PREMATURE POLYMERIZATION | PGF, TTPA, MLN | IDO1 4105/4885NPC1 322/4885RAB9A 4435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.